n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Cognition Disorders in 1 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Medeiros, R | 1 |
Figueiredo, CP | 1 |
Pandolfo, P | 1 |
Duarte, FS | 1 |
Prediger, RD | 1 |
Passos, GF | 1 |
Calixto, JB | 1 |
1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Cognition Disorders
Article | Year |
---|---|
The role of TNF-alpha signaling pathway on COX-2 upregulation and cognitive decline induced by beta-amyloid peptide.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Antibodies; Cognition Disorders; CREB-Binding | 2010 |